4-(2-succinimidyloxycarbonylethyl)phenyl-10-methylacridinium-9-carboxylate has been researched along with Glomerulonephritis, IGA in 1 studies
*Glomerulonephritis, IGA: A chronic form of glomerulonephritis characterized by deposits of predominantly IMMUNOGLOBULIN A in the mesangial area (GLOMERULAR MESANGIUM). Deposits of COMPLEMENT C3 and IMMUNOGLOBULIN G are also often found. Clinical features may progress from asymptomatic HEMATURIA to END-STAGE KIDNEY DISEASE. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Julian, BA; Novak, J; Reily, C; Rizk, DV | 1 |
1 other study(ies) available for 4-(2-succinimidyloxycarbonylethyl)phenyl-10-methylacridinium-9-carboxylate and Glomerulonephritis, IGA
| Article | Year |
|---|---|
Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients.
Topics: Acridines; Animals; Biotinylation; Cells, Cultured; Colorimetry; Enzyme-Linked Immunosorbent Assay; Galactose; Glomerulonephritis, IGA; Glycosylation; Helix, Snails; Humans; Immunoglobulin A; Lectins; Luminescent Measurements; Succinimides | 2018 |